I look at it that Innova has made $4.4 Billion in
Post# of 22453
What's interesting is that Innova bought some production and clinical labs and hired Dr Malan and are pursuing those testing related markets. QMC's use to Innova is the interconnectivity it brings which can increase sales of testing products within the ecosystem. The more connections, the more testing sales, but they are separate businesses. In fact, I don't see much synchrony between Pasaca's other portfolio companies and QMC, but Innova and QMC are two pieces that work together well.
We're hooked up for startup funding of expansion and new products with Pasaca, and we're partners with Innova who's done near $4.5B in sales over just half a year, Oct to March. What's your question about survivability, again?